Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer.

MLA

Peng, Yu, et al. “Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer.” Cancers, vol. 14, no. 24, Dec. 2022, p. 6124. EBSCOhost, https://doi.org/10.3390/cancers14246124.

APA

Peng, Y., Liu, F., Qiao, Y., Wang, P., Du, H., Si, C., Wang, X., Chen, K., & Song, F. (2022). Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer. Cancers, 14(24), 6124. https://doi.org/10.3390/cancers14246124

Chicago

Peng, Yu, Fubin Liu, Yating Qiao, Peng Wang, Han Du, Changyu Si, Xixuan Wang, Kexin Chen, and Fangfang Song. 2022. “Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer.” Cancers 14 (24): 6124. doi:10.3390/cancers14246124.